Literature DB >> 1723917

Coronary vasodilatation induced by endotoxin in the rabbit isolated perfused heart is nitric oxide-dependent and inhibited by dexamethasone.

R E Smith1, R M Palmer, S Moncada.   

Abstract

The coronary vasoconstriction induced by the thromboxane mimetic U46619 (9, 11 dideoxy methanoepoxy 9 alpha, 11 alpha prostaglandin F2 alpha, 3-30 nM) was significantly attenuated in hearts obtained from rabbits treated with endotoxin (lipopolysaccharide, LPS, 200 micrograms kg-1, i.v.) 4 h before isolation of the heart. Under these conditions the vasoconstriction induced by two inhibitors of nitric oxide (NO) synthase, NG-monomethyl-L-arginine (L-NMMA) and N-iminoethyl-L-ornithine (L-NIO) (1-100 microM for each) was significantly enhanced when compared to that induced in hearts from control animals. Both the decreased response to U46619 and the increased response to inhibitors of NO synthase were significantly attenuated by administration of dexamethasone (4 mg kg-1, i.v.) 90 min before treatment with LPS. These data are consistent with the induction, by LPS, of an NO synthase, and the inhibition of this induction by dexamethasone. The enhanced NO synthesis contributes to the haemodynamic changes known to occur in endotoxin shock.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1723917      PMCID: PMC1908266          DOI: 10.1111/j.1476-5381.1991.tb12375.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

2.  Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines.

Authors:  J R Parratt
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

3.  Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator.

Authors:  J L Amezcua; G J Dusting; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

4.  Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock.

Authors:  D D Rees; S Cellek; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

5.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat.

Authors:  R G Knowles; M Salter; S L Brooks; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

7.  The cardiovascular response of normal humans to the administration of endotoxin.

Authors:  A F Suffredini; R E Fromm; M M Parker; M Brenner; J A Kovacs; R A Wesley; J E Parrillo
Journal:  N Engl J Med       Date:  1989-08-03       Impact factor: 91.245

8.  Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit.

Authors:  J L Amezcua; R M Palmer; B M de Souza; S Moncada
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  8 in total
  13 in total

1.  Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium.

Authors:  R Schulz; E Nava; S Moncada
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  Impaired arterial reactivity following cytomegalovirus infection in the immunosuppressed rat.

Authors:  P H Eerdmans; M C Persoons; S J Debets; H A Struijker Boudier; J F Smits; C A Bruggeman; J G De Mey
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism.

Authors:  K F Nilsson; L E Gustafsson; L C Adding; D Linnarsson; P Agvald
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

4.  Impaired vascular sensitivity to nitric oxide in the coronary microvasculature after endotoxaemia.

Authors:  R G Bogle; P G McLean; A Ahluwalia; P Vallance
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

5.  Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs.

Authors:  T Tanazawa; Y Suzuki; M Anzai; S Tsugane; M Takayasu; M Shibuya
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo.

Authors:  J B Warren; R K Loi; M L Coughlan
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

7.  Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.

Authors:  J A Mitchell; K L Kohlhaas; R Sorrentino; T D Warner; F Murad; J R Vane
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  Bacterial endotoxin rapidly stimulates prolonged endothelium-dependent vasodilatation in the rat isolated perfused heart.

Authors:  A R Baydoun; R D Foale; G E Mann
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

9.  Nitric oxide synthase responsible for L-arginine-induced relaxation of rat aortic rings in vitro may be an inducible type.

Authors:  H Moritoki; S Takeuchi; T Hisayama; W Kondoh
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

10.  Contractions induced by potassium-free solution and potassium relaxation in vascular smooth muscle of hypertensive and normotensive rats.

Authors:  P Arvola; I Pörsti; P Vuorinen; A Pekki; H Vapaatalo
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.